Parkinson's disease (PD) as a prevalent neurodegenerative condition impairs motor function
and is caused by the progressive deterioration of nigrostriatal dopaminergic (DAergic) …

As an antagonist of voltage-gated potassium (Kv) channels, 4-aminopyridine (4-AP) is used
as symptomatic therapy in several neurologic disorders. The improvement of visual function …

A series of pyridoxine-resveratrol hybrids were designed and synthesized as monoamine
oxidase B inhibitors for the treatment of Parkinson's disease. Most of them exhibited potent …

A variety of physicochemical methods were used to examine the self-organization,
physicochemical, UV absorption, and fluorescent properties of diluted aqueous solutions …

Parkinson's disease (PD) is the second most common neurodegenerative disorder, which is
associated with a selective loss of dopaminergic neurons in the substantia nigra (SN) and a …

Parkinson's disease is a progressive neurodegenerative disorder characterized by the death
of nerve cells in the substantia nigra of the brain. The treatment options for this disease are …

Quantum-level theoretical studies employing density functional theory and spectral methods
such as Fourier Transform-Raman, Fourier Transform-Infrared, and Ultraviolet–Visible have …

A series of multifunctional 3-piperazinecarboxylate sarsasapogenin derivatives were
designed and synthesized against Alzheimer's disease (AD). The protection against H 2 O 2 …

Abstract Bis [4-(dimethylamino) pyridinium] di-µ-chlorido-bis [dichloridomercurate (II)] has
been achieved from a mixture of mercury (II) chloride in water with an aqueous HCl solution …

The selective MAO‐B inhibition is greatly influenced by the degradation pathways of various
biogenic amines. So the design and development of diverse class of MAO‐B inhibitors are …